Related Experiment Video

Updated: Jan 4, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.7K

MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and

Y-C Wu1, S-Y Li, Y-F Jia

  • 1Department of Endocrinology, The People's Hospital of Linqing, Liaocheng, P.R. China. ekxx46m17307@163.com.

European Review for Medical and Pharmacological Sciences
|November 8, 2019
PubMed
Abstract

Insights

MicroRNA-26a (miR-26a) is down-regulated in papillary thyroid carcinoma (PTC), inhibiting tumor progression and metastasis. Restoring miR-26a levels offers potential therapeutic strategies for PTC.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Papillary thyroid carcinoma (PTC) incidence is increasing globally.
  • MicroRNAs (miRNAs) are critical regulators of carcinogenesis, including PTC.
  • The specific role of miR-26a in PTC progression requires elucidation.

Purpose of the Study:

  • To investigate the biological functions and regulatory mechanisms of miR-26a in papillary thyroid carcinoma.
  • To determine the impact of miR-26a on PTC cell behavior and patient survival.

Main Methods:

  • Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) for miR-26a and ROCK1 mRNA expression.
  • In vitro functional assays (MTT, Transwell) to assess cell viability, invasion, and metastasis.
  • Western blot analysis to evaluate protein expression and pathway involvement (PI3K/AKT, EMT).

Main Results:

  • miR-26a was significantly downregulated in PTC tissues and cells.
  • Low miR-26a expression correlated with advanced clinicopathologic features and poorer survival.
  • miR-26a upregulation suppressed PTC cell viability, invasion, and metastasis.
  • miR-26a targeted ROCK1 and modulated the PI3K/AKT and EMT pathways.

Conclusions:

  • miR-26a exhibits significant anti-tumor properties in papillary thyroid carcinoma.
  • miR-26a acts by targeting ROCK1 and influencing the PI3K/AKT and EMT pathways.
  • miR-26a represents a potential biomarker and therapeutic target for PTC.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.0K
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.8K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K